Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
Seattle hospital won’t turn over gender-affirming care records in lawsuit settlement with Texas
Texas Attorney General Ken Paxton is dropping a re
Israeli military pulls troops from southern Gaza
The Israeli military says it has reduced the numbe